|
Trukhan D.I., Rozhkova M.Yu., Ivanova D.S., Goloshubina V.V.
Cold season: the potential of vitamin-mineral complexes in the prevention and treatment of acute respiratory viral infections
|
№1 / 2024
|
|
Mordyk A.V., Romanova M.A., Shapran A.A., Bagisheva N.V., Moiseeva M.V.
Experience of using tubercular recombinant allergen in examination of school-age children living in rural areas
|
№1 / 2024
|
|
Antonova A.A., Davydova O.V., Davydov M.V., Perova N.Yu., Belyakova I.S., Salikhova M.R., Urudzheva D.Ya.
Public awareness of the use of antibiotics: results of a cross-sectional study (questionnaire survey)
|
№1 / 2024
|
|
Babanov S.A., Ostryakova N.A., Strizhakov L.A., Melentyev A.V., Lysova M.V.
Determinants of development, prediction and prevention of professional burnout in nurses during the COVID-19 pandemic
|
№1 / 2024
|
|
Romanovskikh A.G., Belotserkovskaya Yu.G., Smirnov I.P., Klyachkina I.L.
Modern possibilities of combined pharmacotherapy for cough
|
№1 / 2024
|
|
Trushina E.Yu., Kostina E.M., Tipikin V.A., Orlova E.A.
Triple therapy in the treatment of patients with a combination of chronic obstructive pulmonary disease and bronchial asthma
|
№1 / 2024
|
|
Kostina E.M., Trushina E.Yu., Tipikin V.A., Orlova E.A.
Phenotype of bronchial asthma with fixed obstruction
|
№1 / 2024
|
|
Trofimenko I.N., Chernyak B.A.
Modern possibilities of bronchodilation therapy for patients with chronic obstructive pulmonary disease
|
№1 / 2024
|
|
Trukhan D.I., Sulimov A.F., Trukhan L.Yu.
Orofacial pain as a manifestation of myocardial ischemia
|
№1 / 2024
|
|
Shuvalova A.S., Prokofieva T.V., Polunina O.S., Polunina E.A.
Association of N-terminal pro C-type natriuretic peptide and endothelin-1 levels with the risk of cardiovascular complications in arterial hypertension six months after COVID-19
|
№1 / 2024
|
|
Orlova I.Yu., Batyukina S.V., Kochetkov A.I., Piksina G.F., Plotnikova N.A., Ostroumova O.D.
State of cognitive functions in patients with various forms of atrial fibrillation
|
№1 / 2024
|
|
Izmozherova N.V., Grenaderova M.A., Shambatov M.A., Popov A.A., Kudryavtseva E.V., Bortnik A.E., Vishneva K.A., Shamilov M.D.
The use of angiotensin II type 1 receptor antagonists in the treatment of chronic heart failure against the background of the renin-angiotensin-aldosterone system genetic polymorphisms
|
№1 / 2024
|
Русский
